施競

施競, listed as chief executive, appears in our data through filings on 沃森生物 shares, published by SSE / SZSE (CSRC). We count 2 filings; the first trade dates from 27 December 2022 and the latest from 5 January 2023.

Every open-market trade on record is a sale: 2 sales worth €1.5M. Since January 2023: no purchases and 1 sale on the market.

The latest filing, published on 5 January 2023, reports an open-market sale of €971k in 沃森生物. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.